DESROSIER THOMAS (See Remarks) sold 1.0% of their position (78.00 shares) of SERES THERAPEUTICS, INC. on the open market
Open‑market sale worth $660.66 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/18/2026ACC: 0001193125-26-057154
Officer· See Remarks
Since Mar 2026
-78.00
Net shares
Net seller
$660.66
Total sold
1
Open market trades
0B · 1S
4
Total transactions
244.00 acquired · 322.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+244.00
Price / share
—
Trade value
—
% of position
3.2%
2/15/2026
7.62K→7.87K
Common Stock
Direct
Shares
−78.00
Price / share
$8.47
Trade value
$660.66
% of position
1.0%
2/15/2026
7.87K→7.79K
Total
Net shares
+166.00
Net value
-$660.66
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2026 | M · Option Exercise | +244.00 | — | — | 3.2% | 7.62K | 7.87K |
| Common Stock Direct | 2/15/2026 | S · Sale | −78.00 | $8.47 | $660.66 | 1.0% | 7.87K | 7.79K |
| Total | +166.00 | -$660.66 | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
133.00 shares
Shares
−133.00
Strike price
Held after
531.00
Exercisable
—
2/15/2026
Restricted Stock Units
Direct
Converts to
Common Stock
111.00 shares
Shares
−111.00
Strike price
Held after
890.00
Exercisable
—
2/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock133.00 shares | 2/15/2026 | M · Option Exercise | −133.00 | — | 531.00 | |
| Restricted Stock Units Direct | Common Stock111.00 shares | 2/15/2026 | M · Option Exercise | −111.00 | — | 890.00 |